healthday18h
Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within One Year
Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...
Is Ozempic safe for weight loss? What doctors want you to know about blockbuster drug
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
Doctors welcome Welsh ban on BOGOF deals and checkout placement for these 16 foods
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
6 numbers to know about heart and brain health
Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...
Lancashire Telegraph on MSN12h
These Lancashire towns are among places with highest number of takeaways
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Northumberland Gazette23h
Data shows two thirds of adults in Northumberland are overweight
Data from Northumberland County Council shows that just a third of adults in the county are at a healthy weight.
Wrexham.com8h
Welsh Government curbs on sugary drinks refills and multi-buy offers welcomed by doctors’ union
A doctors’ union has welcomed plans by the Welsh Government to introduce restrictions on the promotion and placement of foods high in fat, salt and sugar.
wusf2h
Could obesity drugs help with alcohol cravings? A new study suggests potential
The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. But the results add to evidence that GLP-1 drugs like Ozempic might help with cravings for things ...
Novo Nordisk A/S (NYSE:NVO) Coverage Initiated by Analysts at Morgan Stanley
Morgan Stanley began coverage on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a research report released on ...